Astrana Health, INC 8-K filings
NASDAQ
Astrana Health announced its third-quarter 2024 financial results, showing strong revenue growth but a decline in net income and adjusted EBITDA compared to the same period last year.
NASDAQ
8-K: Astrana Health Completes Acquisition of Collaborative Health Systems and Other Physician Networks
Astrana Health, Inc. finalized the acquisition of Collaborative Health Systems, LLC, Golden Triangle Physician Alliance, and Heritage Physician Networks on October 4, 2024.
NASDAQ
Astrana Health, Inc. has released an investor presentation containing financial information for use in upcoming conferences.
NASDAQ
Astrana Health announced a 40% increase in total revenue and a 46% increase in net income for the second quarter of 2024, driven by organic growth and strategic acquisitions.
NASDAQ
Astrana Health has entered into a definitive agreement to acquire Collaborative Health Systems for an initial $37.5 million, expanding its value-based care capabilities.
NASDAQ
8-K: Astrana Health Files Prospectus Supplement for Resale of Earn-Out Shares Related to AAMG Acquisition
Astrana Health has filed a prospectus supplement for the potential resale of shares related to its acquisition of Asian American Medical Group.
NASDAQ
Astrana Health has amended its Restated Certificate of Incorporation to exculpate certain officers from liability in specific stockholder claims, effective June 13, 2024.
NASDAQ
Astrana Health, Inc. stockholders approved the 2024 Equity Incentive Plan, replacing the 2015 plan, at the annual meeting on June 12, 2024.
NASDAQ
Astrana Health has amended its credit agreement to allow for letters of credit that extend beyond the agreement's maturity date.
NASDAQ
Astrana Health released an investor presentation detailing its financial performance, value-based care model, and growth strategy.
NASDAQ
Astrana Health announced a 20% increase in revenue, a 13% rise in net income, and a 42% jump in adjusted EBITDA for the first quarter of 2024, fueled by membership growth and effective cost management.
NASDAQ
Astrana Health, Inc. has eliminated its Series A and B Convertible Preferred Stock, returning those shares to authorized but unissued status.
NASDAQ
Astrana Health, Inc. has announced that Dr. Albert Young has transitioned from Chief Administrative Officer to Senior Vice President of Health Affairs, effective April 23, 2024.
NASDAQ
Astrana Health, Inc. has amended and restated employment agreements for its CEO and COO/CFO, and granted them significant long-term equity incentives.
NASDAQ
Astrana Health, Inc. has completed the acquisition of Advanced Health Management Systems, L.P. and 25% of I Health, Inc., finalizing amended purchase agreements.
NASDAQ
Astrana Health released an investor presentation detailing its financial performance, growth strategy, and future outlook, emphasizing its technology-driven, provider-centric healthcare platform.
NASDAQ
Astrana Health, Inc. has updated its bylaws to include new procedures for shareholder nominations and proxy solicitations, and has set the date for its 2024 annual meeting.
NASDAQ
Astrana Health announced its fourth quarter and year-end 2023 financial results, showcasing significant revenue growth and increased profitability.
NASDAQ
Astrana Health, Inc. officially changed its name from Apollo Medical Holdings, Inc. and amended its by-laws to reflect the change, effective February 26, 2024.
NASDAQ
Apollo Medical Holdings has completed the first closing of its acquisition of Community Family Care Medical Group IPA's assets and amended its purchase agreement for Advanced Health Management Systems.
NASDAQ
Apollo Medical Holdings, Inc. will change its name to Astrana Health, Inc., effective February 26, 2024, with a corresponding ticker symbol change from AMEH to ASTH.
NASDAQ
Apollo Medical Holdings has appointed a new CEO and COO, while also announcing a corporate name change to Astrana Health Inc.